Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.
Previous studies in rodents have reported that clonidine, an alpha 2-adrenergic receptor agonist, attenuated conditioned aversions to naloxone-precipitated opiate withdrawal when administered prior to each withdrawal conditioning episode. The current study was designed to determine whether clonidine could modify the expression of previously established conditioned place aversions and conditioned suppression of operant responding. Dose- and time-dependent effects of clonidine on activity and suppression of operant responding for food identified appropriate treatment parameters for subsequent studies in which rats rendered dependent on opiates through implantation of morphine pellets were tested for: (1) conditioned place aversion; and (2) conditioned suppression of operant responding for food (fixed ratio-15 schedule), in a paradigm wherein rats received four pairings of naloxone with a distinct tone and odor stimulus. Clonidine dose-dependently blocked the acquisition of both conditioned behaviors when administered prior to naloxone on each conditioning trial, but was ineffective in blocking the expression of these conditioned withdrawal signs when administered prior to the test session.
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California, USA.
G
G
Schulteis
L
L
Stinus
V B
VB
Risbrough
G F
GF
Koob
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000701:Analgesics, Opioid / Q000633:toxicity*; D000818:Animals; D003000:Clonidine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects*; D008297:Male; D009020:Morphine / Q000633:toxicity*; D009270:Naloxone; D009294:Narcotics / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013375:Substance Withdrawal Syndrome
D000316:Adrenergic alpha-Agonists; D000701:Analgesics, Opioid; D009294:Narcotics; D009270:Naloxone; D009020:Morphine; D003000:Clonidine